Continuous extraovular prostaglandin F2 alpha instillation for second-trimester pregnancy termination

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Pharmacological Interventions

Background:

• Midtrimester pregnancy termination requires effective and safe induction methods.
• Continuous extraovular infusion presents a potential alternative for labor induction.

Purpose of the Study:

• To evaluate the efficacy and safety of continuous extraovular infusion of prostaglandin F2 alpha (PGF2 alpha) for midtrimester pregnancy termination.

Main Methods:

• One hundred patients underwent midtrimester pregnancy termination.
• Prostaglandin F2 alpha (PGF2 alpha) was continuously infused into the extraovular space using a novel double-balloon catheter.

Main Results:

• The mean induction-to-abortion time was 12.9 hours.
• 96% of patients delivered within 24 hours.
• Side effects were infrequent, including nausea, vomiting, and transient pyrexia, with no major complications.

Conclusions:

• Continuous extraovular infusion of PGF2 alpha is a highly successful method for midtrimester pregnancy termination.
• The procedure offers good patient tolerance and an acceptable safety profile with minor side effects.